SCHEMBL4075354

SCHEMBL4075354

COc1cc2ncc(C(N)=O)c(Nc3ccc(Cl)c(Cl)c3)c2cc1Br

nearest known ligand 0.85

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 19/20 0.85
EGFR P00533 1/20 0.64
ERBB2 P04626 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913279 0.87 CSF1R (0.64) CSF1REGFR
SCHEMBL4441524 0.85 CSF1R (0.79) CSF1R
SCHEMBL27768805 0.84 CSF1R (0.77) CSF1R
SCHEMBL4442692 0.83 CSF1R (0.76) CSF1REGFR
SCHEMBL5929801 0.83 CSF1R (1.00) CSF1REGFR
SCHEMBL2908163 0.83 CSF1R (0.64) CSF1REGFR
SCHEMBL2909935 0.82 CSF1R (0.85) CSF1R
SCHEMBL4072127 0.82 CSF1R (0.71) CSF1REGFR
SCHEMBL2905491 0.82 CSF1R (1.00) CSF1R
SCHEMBL2912117 0.81 CSF1R (0.83) CSF1REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101611011-A Compound ASTRAZENECA AB (SE) 2009-12-23 CN disclosed
US-20090270450-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-10-29 US disclosed
EP-2084134-A1 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2009-08-05 EP disclosed
WO-2008056148-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270450-A1 CHEMICAL COMPOUNDS CSF1R, CSF3R, FLT3 CSF1R 1/4885EGFR 415/4885ERBB2 266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.